Your healthcare team will likely recommend appropriate blood glucose monitoring based on your individual needs, regular weight measurements, and an HbA1c test within 3 months of discontinuation to ensure your diabetes remains well controlled
Resources (low) (inverse)
By month 6, cumulative losses of 20-35 pounds are common, representing a 10-17.5% reduction in starting body weight
For patients who cannot tolerate statins or need additional lipid lowering, NICE-approved alternatives include ezetimibe, PCSK9 inhibitors (evolocumab, alirocumab), bempedoic acid, inclisiran, and fibrates for specific indications
Understanding Georgia GLP-1 Lawsuits Patients across Georgia are beginning to join weight loss drug lawsuits against pharmaceutical companies over the dangerous side effects linked to GLP-1 receptor agonist drugs like Ozempic, Wegovy, and Rybelsus
mean HbA1c, 7.8%)